Free Trial

Nomura Holdings Inc. Invests $595,000 in Maximus, Inc. (NYSE:MMS)

Maximus logo with Business Services background

Nomura Holdings Inc. bought a new position in Maximus, Inc. (NYSE:MMS - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 7,970 shares of the health services provider's stock, valued at approximately $595,000.

A number of other institutional investors have also modified their holdings of the stock. UMB Bank n.a. grew its stake in Maximus by 79.8% in the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock worth $27,000 after purchasing an additional 158 shares in the last quarter. V Square Quantitative Management LLC lifted its holdings in shares of Maximus by 65.9% in the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock worth $34,000 after buying an additional 180 shares during the period. R Squared Ltd purchased a new stake in shares of Maximus in the 4th quarter worth $54,000. IFP Advisors Inc grew its position in shares of Maximus by 62.4% during the 4th quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock worth $59,000 after buying an additional 302 shares in the last quarter. Finally, Farther Finance Advisors LLC increased its stake in shares of Maximus by 109.2% during the fourth quarter. Farther Finance Advisors LLC now owns 820 shares of the health services provider's stock valued at $61,000 after buying an additional 428 shares during the period. 97.21% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Maximus

In other Maximus news, Director Jan Madsen sold 2,439 shares of Maximus stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total value of $165,144.69. Following the transaction, the director now directly owns 18,097 shares of the company's stock, valued at approximately $1,225,347.87. The trade was a 11.88% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.60% of the company's stock.

Maximus Stock Down 1.8%

MMS stock traded down $1.33 during trading on Monday, hitting $72.36. 456,402 shares of the company's stock traded hands, compared to its average volume of 562,495. The firm has a market capitalization of $4.08 billion, a P/E ratio of 15.56 and a beta of 0.61. The business has a fifty day simple moving average of $69.37 and a two-hundred day simple moving average of $72.05. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $93.97.

Maximus (NYSE:MMS - Get Free Report) last announced its earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.37 by $0.64. Maximus had a return on equity of 21.95% and a net margin of 5.28%. The business had revenue of $1.36 billion for the quarter, compared to analysts' expectations of $1.29 billion. During the same quarter last year, the firm earned $1.57 EPS. The business's revenue for the quarter was up 1.0% on a year-over-year basis. Sell-side analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th will be paid a $0.30 dividend. The ex-dividend date is Thursday, May 15th. This represents a $1.20 annualized dividend and a yield of 1.66%. Maximus's dividend payout ratio (DPR) is presently 23.86%.

Analysts Set New Price Targets

Separately, Wall Street Zen cut shares of Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th.

Check Out Our Latest Research Report on MMS

About Maximus

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Featured Stories

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Should You Invest $1,000 in Maximus Right Now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why AMD Stock Beats NVIDIA Right Now
Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now
Palantir at All-Time Highs: Take Profits or Hold the Line?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines